Although no significant change in FBG was found in human participants after the COVID‐19 mRNA booster shots (Figure 5F and Table S2), 43 of 65 (66.1%) patients with diabetes had impaired insulin sensitivity according to the HOMA‐IR and an increased risk of metabolic dysfunction according to the TyG index. This evidence concerns the gene INS and diabetes mellitus.